← Oncology Approval Tracker

FDA DECISION ·

Margenza + chemotherapy

margetuximab-cmkb + chemotherapy · MacroGenics

FDA approvalNew therapyBreast cancer
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Adults with metastatic HER2-positive breast cancer after at least two HER2-directed regimens, at least one in the metastatic setting.

LAMPGEN ANALYSIS

Why it matters

Added a HER2-directed antibody combined with chemotherapy after prior HER2 treatment.

What research teams should watch

Confirm prior regimen setting, and plan infusion reaction and cardiac monitoring.

PRIMARY RECORDS

Sources